https://angleplc.com/ | Anchor | Skip to content |
https://angleplc.com/ | | IMG-ALT Angle logo |
https://angleplc.com/about-us/ | | About us |
https://angleplc.com/about-us/ | | Discover ANGLE |
/about-us/our-team/ | | Our team |
/about-us/careers/ | | Careers |
/about-us/events/ | | Events |
https://angleplc.com/news/ | | News |
/about-us/corporate-social-res... | | Corporate social responsibility |
/parsortix-technology/ | | Technology |
/parsortix-technology/ | | Parsortix® technology |
/the-parsortix-pc1-system/ | | Parsortix PC1 system – clinical |
/parsortix-pr1/ | | Parsortix PR1 system – research |
/product-solutions/ | | Product solutions |
/product-solutions/ | | Discover all Product solutions |
/the-parsortix-pc1-system/ | Textduplikat | Parsortix PC1 system – clinical |
/parsortix-pr1/ | Textduplikat | Parsortix PR1 system – research |
/portrait-plus/ | | Portrait+ CTC Staining Kit |
/laboratory-services/ | | Laboratory services |
/laboratory-services/ | | Discover all Laboratory services |
/laboratory-services/enumeration/ | | Enumeration |
/laboratory-services/portrait-... | | Portrait®Flex |
/laboratory-services/dna-damag... | | DNA damage response (DDR) |
/laboratory-services/portrait-... | | Portrait®PD-L1 |
/laboratory-services/custom-ct... | | Custom CTC assays |
/laboratory-services/her2/ | | HER2 |
https://angleplc.com/resources/ | | Resources |
https://angleplc.com/resources/ | | View all resources |
/resources/publications/ | | Publications |
/resources/posters/ | | Posters |
/resources/articles/ | | Articles |
/resources/whitepapers/ | | Whitepapers |
/resources/presentations/ | | Presentations |
/translational-research/ | | Translational research |
/translational-research/breast... | | Breast cancer |
/translational-research/prosta... | | Prostate cancer |
/translational-research/ovaria... | | Ovarian cancer |
https://angleplc.com/ivd-ifu/ | | Instructions for Use documents |
/product-information/ | | Product information |
https://angleplc.com/contact-us/ | | Contact us |
/information-for-investors-ang... | | Investors |
/information-for-investors-ang... | Textduplikat | Investors |
/information-for-investors-ang... | | Business strategy |
/information-for-investors-ang... | | Market size |
/information-for-investors-ang... | | Regulatory news |
/information-for-investors-ang... | | Share price |
/information-for-investors-ang... | | Financial reports |
/information-for-investors-ang... | | Financial Calendar |
/information-for-investors-ang... | | Corporate responsibility report |
/information-for-investors-ang... | | Glossary |
/information-for-investors-ang... | | Email alerts |
/information-for-investors-ang... | | AIM Rule 26 |
/information-for-investors-ang... | | Corporate governance |
/information-for-investors-ang... | | Significant shareholders |
/information-for-investors-ang... | | ADR |
/information-for-investors-ang... | | Advisors |
/information-for-investors-ang... | | Corporate presentations |
/information-for-investors-ang... | | ANGLE in the media |
/information-for-investors-ang... | | Analyst research |
/wp-content/uploads/2024/06/AN... | | Open PDF |
https://angleplc.com/about-us/ | Textduplikat | Discover ANGLE |
/about-us/our-team/ | Textduplikat | Our team |
/about-us/careers/ | Textduplikat | Careers |
/about-us/events/ | Textduplikat | Events |
/about-us/corporate-social-res... | Textduplikat | Corporate social responsibility |
/parsortix-technology/ | | Parsortix®technology |
/the-parsortix-pc1-system/ | Textduplikat | Parsortix PC1 system – clinical |
/parsortix-pr1/ | Textduplikat | Parsortix PR1 system – research |
/product-solutions/ | Textduplikat | Discover all Product solutions |
/portrait-plus/ | | Portrait+ CTC staining kit |
/the-parsortix-pc1-system/ | Textduplikat | Parsortix PC1 system – clinical |
/parsortix-pr1/ | Textduplikat | Parsortix PR1 system – research |
/laboratory-services/ | Textduplikat | Discover all Laboratory services |
/laboratory-services/enumeration/ | | CTC enumeration |
/laboratory-services/portrait-... | Textduplikat | Portrait®Flex |
/laboratory-services/dna-damag... | Textduplikat | DNA damage response (DDR) |
/laboratory-services/portrait-... | Textduplikat | Portrait®PD-L1 |
/laboratory-services/custom-ct... | Textduplikat | Custom CTC assays |
/laboratory-services/her2/ | Textduplikat | HER2 |
https://angleplc.com/resources/ | | Discover all Resources |
/resources/publications/ | Textduplikat | Publications |
/translational-research/ | Textduplikat | Translational research |
https://angleplc.com/ivd-ifu/ | Textduplikat | Instructions for Use documents |
/product-information/ | Textduplikat | Product information |
https://angleplc.com/contact-us/ | Textduplikat | Contact us |
/information-for-investors-ang... | Textduplikat | Investors |
/information-for-investors-ang... | Textduplikat | Business strategy |
/information-for-investors-ang... | Textduplikat | Market size |
/information-for-investors-ang... | Textduplikat | Regulatory news |
/information-for-investors-ang... | Textduplikat | Share price |
/information-for-investors-ang... | Textduplikat | Financial reports |
/information-for-investors-ang... | Textduplikat | Financial Calendar |
/information-for-investors-ang... | Textduplikat | Corporate responsibility report |
/information-for-investors-ang... | Textduplikat | Glossary |
/information-for-investors-ang... | Textduplikat | Email alerts |
/information-for-investors-ang... | | AIM 26 |
/information-for-investors-ang... | Textduplikat | Corporate governance |
/information-for-investors-ang... | Textduplikat | Significant shareholders |
/information-for-investors-ang... | Textduplikat | ADR |
/information-for-investors-ang... | Textduplikat | Advisors |
/information-for-investors-ang... | Textduplikat | Corporate presentations |
/information-for-investors-ang... | Textduplikat | ANGLE in the media |
/information-for-investors-ang... | Textduplikat | Analyst research |
/about-us/events/ | Neues Fenster | Discover More |
/parsortix-technology/ | | Discover more |
/parsortix-technology/the-pars... | Textduplikat | Discover more |
/onc-adapt-laboratories/ | Textduplikat | Discover more |
/parsortix-technology/the-pars... | Textduplikat | Discover more |
/onc-adapt-laboratories/ | Textduplikat | Discover more |
/publications/ | Textduplikat | Discover more |
/wp-content/uploads/2024/09/Lo... | Neues Fenster Textduplikat | Open PDF |
/wp-content/uploads/2024/08/Id... | Neues Fenster Textduplikat | Open PDF |
/wp-content/uploads/2024/08/20... | Neues Fenster Textduplikat | Open PDF |
/wp-content/uploads/2024/08/Co... | Neues Fenster Textduplikat | Open PDF |
https://angleplc.com/contact-us/ | Textduplikat | Contact us |
https://angleplc.com/about-us/ | Textduplikat | About us |
/parsortix-technology/ | Textduplikat | Technology |
/product-solutions/ | Textduplikat | Product solutions |
/laboratory-services/ | Textduplikat | Laboratory services |
https://angleplc.com/resources/ | Textduplikat | Resources |
/information-for-investors-ang... | Textduplikat | Investors |
https://angleplc.com/contact-us/ | Textduplikat | Contact us |
https://angleplc.com/ | | Kein Text |
https://www.google.com/maps/pl... | Neues Fenster Extern Subdomain | 2 Occam Court, Occam Road, Surrey Research Park, Guildford, GU2 7QB, UK |
https://www.google.com/maps/pl... | Neues Fenster Extern Subdomain | 5100 Campus Drive, Suite 120, Plymouth Meeting, PA 19462, USA |
https://www.google.com/maps/pl... | Neues Fenster Extern Subdomain | 10 Nugent Road, Surrey Research Park, Guildford, GU2 7AF, UK |
/privacy-policy/ | | Privacy policy |
/cookies-declaration/ | | Cookies declaration |
/terms-conditions/ | | Terms & conditions |
https://twitter.com/parsortix?... | Neues Fenster Extern | Kein Text |
https://www.linkedin.com/compa... | Neues Fenster Extern Subdomain | Kein Text |
(Nice to have)